CURRICULUM VITAE - OU Medicine

4/23/13
CURRICULUM VITAE
GILLIAN M. AIR
Address:
University of Oklahoma Health Sciences Center
Dept. of Biochemistry and Molecular Biology, BMSB 840
P.O. Box 26901
Oklahoma City OK 73190
Phone 405) 271-2227 ext'n 1250
fax (405) 271-3205
e-mail
gillian-air@ouhsc.edu
Education:
Undergraduate: The University of Sydney, B.Sc. (Hons) in Biochemistry, 1967.
Graduate: The University of New South Wales, Ph.D. in Biochemistry, 1971.
Postdoctoral:
Beit Memorial Fellow, MRC Laboratory of Molecular Biology, Cambridge, England
(Dr. Ieuan Harris, Dr. Fred Sanger), September 1970 - August 1973.
Professional appointments:
September 1973 – December 1976
January 1977 – December 1981
January 1982 – September 1985
October 1985 – June 1996
Scientific Staff, MRC Laboratory of Molecular Biology,
Cambridge, England.
Queen Elizabeth II Fellow, Research Fellow, Senior Research
Fellow, Dept of Microbiology, John Curtin School of Medical
Research, Australian National University.
Associate Professor of Microbiology (tenured), University of
Alabama at Birmingham.
Professor of Microbiology, University of Alabama at Birmingham.
July 1996 – present
Professor of Biochemistry and Molecular Biology, University of
Oklahoma Health Sciences Center.
1997 – 2006 Director, Biochemistry & Molecular Biology Graduate Program
2007 – present George Lynn Cross Research Professor
2007 – present Vice-chair, Department of Biochemistry & Molecular Biology
1

Gillian M. Air
Honors and Awards:
Beit Memorial Fellowship for Medical Research, 1970-73
Queen Elizabeth II Fellowship for Medical Research, 1977-81.
NIH MERIT award 1991 – 2001
Fellow, American Association for the Advancement of Science (AAAS), 2001.
Edith Kinney Gaylord Presidential Professor. 2001–2005
George Lynn Cross Research Professor, 2007 - present
Graduate Teaching and Graduate Program Administration
University of Alabama at Birmingham 1982-1996
Principal Investigator, Cell and Molecular Biology Training Grant 1992–1996
This grant from NIGMS supported the interdisciplinary first year program in basic science
departments. It was renewed, with increased number of stipends, while I was PI. I left UAB in
1996.
Principal Investigator, Basic Mechanisms in Virology Training Grant 1993–1996.
This training grant from NIAID was also renewed while I was PI.
Coursemaster for:
Cell and Molecular Biology Graduate Program: CMBIII (Virology) 1984 –1985.
CMB Literature review: 1982 –1983.
Freshman Medical Microbiology, Virology section, 1986 –1989
CMB I (Biochemistry) 1990 – 1993
CMB Journal Club 1995 – 1996
Classes:
CMB Graduate Program core curriculum:
I taught about 6 classes each year on proteins, nucleic acids, virology
Advanced courses for graduate students: lectures in
Protein structure (1984, 1986, 1990, 1993, 1995)
Immunogenetics (1985, 1988),
Bio-Organic Chemistry (1987, 1989, 1996),
Genetics (1987),
Molecular Biology for Clinical Fellows (1987).
Virus Assembly (1992)
Medicinal Chemistry (1995)
Virology for Medical and Dental students: influenza viruses. 2–3 lectures per year.
2

Gillian M. Air
University of Oklahoma Health Sciences Center 1996–present
Director, Biochemistry & Molecular Biology Graduate Program 1997 – 2006
Course Coordinator:
BMSC 6016 (Cellular & Molecular Biochemistry I) 1999 – 2001
BMSC 6032 (Cellular & Molecular Biochemistry II) 1999 – 2001
BIOC 6990-744 (Current Issues) 1998 – 2000
Summer Undergrad. Journal Club (1999, 2000)
BIOC 6321 & 6341, overall coordinator Spring 2004 – 2006
BIOC 6221-700 (Noddy Tern Journal Club) 1997 – present
GPIBS Molecular Systems I & II, co-coordinator 2003 – 2008, 2010
BIOC 6221 Molecular Virology (with John West)
BMSC 5001 Scientific Integrity Fall 2005 - present
Classes taught:
GPIBS Mol Systems I: Protein structure (3 hr)
Transcription module: viral transcription (3 hr)
Virology module: receptors, vaccines, evolution (4.5 hr)
Scientific Integrity course: Ethical decision-making, Peer review, Mentoring (3 hr)
Noddy Tern Journal Club, (2 hr)
Dept. Microbiol. & Immunol: Advanced Virology (3 hr).
MS1 INDT 8303 Enrichment (Biomed literature) (2 hrs)
Other classes:
Norman Campus: Dept. Chemistry & Biochemistry
Advanced Protein Structure (1997)
Biochemistry Honors Program (Undergrad) (1999)
Graduate students from my lab:
Janet Blok PhD, graduated 1982 Teaching
Mike Lentz PhD, graduated June 1986 Assoc Prof. Univ. N. Florida
Maryna Els Eichelberger PhD, graduated June 1989 Principal Investigator, Division of Viral
Products, FDA
Pat Bossart-Whitaker PhD, graduated March 1992 Teaching
Jackie Nuss Parker PhD, graduated June 1993 Research Associate Professor, Pediatrics,
Univ. Alabama at Birmingham
Pamela Pruett PhD, graduated April, 1996 Research Associate, Center for Biophysical
Sciences and Engineering, Univ. Alabama
at Birmingham
Hong Zhang PhD, graduated August, 1995 CSO, Z-Biomed Inc, Rockville MD
Anita Ghate Latham PhD, graduated May 99 Lecturer, Univ. Texas at Austin
Stephen Stray PhD, graduated August 2000 Assistant Professor, Dept Microbiology,
University of Mississippi, Jackson MS.
Janis Lee PhD, graduated Dec 2004 Postdoc, CUNY Brooklyn
3

Gillian M. Air
Xiaoju Zhang MS, graduated Dec 2007 PhD program, Univ. Rochester, NY
Albert Nguyen
Lyuba Popova
Mary Tappert
MD/PhD program (M&I),
graduated 2009,2011
PhD (OU Norman), graduated
June 2012
MD/PhD program, graduated
June 2012
Co-Chair with Mike Sakalian.
Committee member for Ph.D. students:
UAB: Allen Zell (Biochem), John Pfeiffer (Micro), Gary Davis (Micro), David Bole (Micro), Lautaro
Perez (Micro), Ken Roland (Micro), Mike Roth (Micro), Liming Shu (Biochem), Mark Walter (Biochem),
Qi Wu (Micro), Brian Gaupp (Micro), Karen Mullis (Biochem), Al Torri (Biochem), Helen Wilson (Micro),
Jeong Hong (Biochem), Tom Ryan (Biochem), Sung Rhee (Micro), Jeff Fredman (Biochem), Sandra
Jablonski (Micro), Jianyun Dong (Micro), John Caterina (Biochem), David Einfeld (Micro), Patrick
Johnson (Micro), Li Li (Micro), Sunghee Kim (Micro), Kenneth Toth (Biochem), Clinton White
(Biochem), Perry Kirkham (Micro), David Donze (Biochemistry), Sharon Michael (Biochemistry),
Thomas Easterwood (Biochemistry), Anina Murphy (Microbiology), Barbara Mulach (Biochemistry),
Elise Keddie (Microbiology), Ling Li (Microbiology), Karl Salzwedel (Microbiology), Barclay Browne
(Microbiology),
Past OUHSC Doctoral Committees: Coy Heldermon, Haiying Qiu, Xingping Xu (Norman campus),
Anna Kateneva, Robert Turner, Christina Bourne, Philip Coburn (Micro. & Immunol.), Leann Godderz,
Janis Lee (chair), Howard Ziserman, Laura Pollard, David Sparling, Jun Peng, Jian Liu, Sarah Katen,
Angela Wahl (Microbiology), Albert Nguyen (Microbiology, Co-Chair), Zhao Wang, Zach Porterfield,
Shuying Zhao, Liang Wang, Bojing Shao, Nigel Otto, Lauren Ritterhouse (Pathology), Ioana Boeras
(Microbiology), Lyuba Popova (OU Norman, Co-Chair), Mary Tappert (chair), Sarah Kim (Cell Biology)
External PhD examiner for Jacqueline Upham, Univ. of Melbourne 2005; Jiwon Ha, University of
Sydney 2012.
Past OUHSC MS committees: Pablo Ceres, Ana Maria Garcea, Xiaoju Zhang (chair), Mahdu Pandey
Current doctoral committees at OUHSC: Carlie Milfort (Cell Biology), Abigail Smith (Microbiology),
Feng He.
4

Gillian M. Air
NATIONAL AND INTERNATIONAL ACTIVITIES
Editorial Board, Virology, 1987 – present
Editorial Board, Journal of Virology, 2007 – 2015
Advisory Board, BMC Virology Journal, 2006 – 2012, Associate Editor, 2012- present)
Ad hoc reviewer for:
Biochemistry, J. Molecular Biology, J. Infectious Diseases, J. Gen. Virol, Virus Research, Antimicrobial
Agents and Chemotherapy, Proc. Nat’l Acad. Sci., Vaccine, J Clin Virol., J. Immunol., Glycoconjugate
J., Trends in Microbiology, Science, Nature Biotechnology, PLOS Pathogens, PLoS One,
Glycobiology, Nature Communications.
Total manuscripts reviewed 2012 ~ 20.
Completed “Management Institute for Women in Higher Education” at Wellesley College, MA, 2002-
2003.
Member: American Chemical Society, American Society for Virology, American Society for
Biochemistry & Molecular Biology, American Society for Microbiology.
Consultant: Biocryst Pharmaceuticals Inc. 1994–2001; Dyax Corp 2004–2007; Z-Biomed 2004–2009.
American Society for Virology, Annual Meeting Program Planning Committee 2008-2010
Member: Scientific Working Group, NIAID Influenza Research Database 2007–present
Consortium for Functional Glycomics, Subgroup 1 Leader (Microorganism recognition of host
glycans) 2008-2012
Member, Scientific Advisory Board, St Jude’s Hospital Center of Excellence for Influenza
Research and Surveillance, 2010 to present
Member, FDA Vaccines and Related Biological Products Advisory Committee, 2011-2015
Secretary, AAAS Medical Sciences Section, 2013-2017
National Grant Review Committees:
March 1988, October 1988, March 1991 NIH ad hoc on Immunology and special study sections
July 1991–June, 1995 Member, NIH Experimental Virology Study Section (EVR).
July 1995 - June 1998 NIH Reviewers Reserve, EVR and Fellowship study sections
February 1998 USDA Review Team, Dept. Biochemistry, Univ. Nevada-Reno
July 1998 – June 2001 Member, NIH Biophysical Chemistry Study Section (BBCB)
April and August 2000 NIH Special Review Panel: Challenge grants for influenza vaccines
March 2003 NIAID Review Panel: Vaccines, Adjuvants, Therapeutics & Diagnostics for Biodefense
June, 2003 NIAID Review Panel: Biodefense and Emerging Infectious Diseases
July 2003 NIH Special Emphasis Panel: Hepatitis C.
December 2003 NIH Vaccine-06 Study Section (SARS).
April 2004 NIAID Review Panel Cooperative Centers for translational research on human immunology
and biodefense
June 2004 – June 2009 Member, NIH Vaccines for Microbial Diseases (VMD) Study Section
(constituted July 2005)
5

Gillian M. Air
Nov 2005 - NIAID Review Panel: Assays for Influenza Therapeutics
May 2006 - CDC Grant Review Panel for influenza (Chair).
November 2007 - NIAID Grant Review Panel for pandemic influenza (Chair)
April 2009 - NIAID Program Project Review Panel 1918 influenza (Chair)
January 2010 - NIAID grant review panel for Influenza P01.
April 2010 – NIAID contract review panel “Modeling Immunity for Biodefense”
Sept 2010 – British Biotechnology and Biological Sciences Research Council, grant review
January 2011 – NIAID P01 review
February 2011 – NIH VIRB study section mail reviewer
February 2011 – Austrian Research Organization – grant review
October 2011 – NIH VIRB study section
December 2011 – NIAID P01 review panel B cell memory
Aug 2012 – NIH Immunology Reviewer Conflicts study section.
Feb 2013 – FDA Site visit of DNA virus laboratory
Apr 2013 NIH CSR Virology Reviewer Conflicts study section
Invited speaker: International
Nov 1982 - Conference on "The Origin of Pandemic Influenza Viruses". Beijing, China.
Feb 1982 - WHO Workshop on the Ecology of Influenza Viruses. London, England.
Sept. 1984 - International meeting on influenza hemagglutinin, Greenpia Miki, Japan.
Sept. 1985 - The Biology of Negative strand viruses. Cambridge, England.
Oct 1985 - Symposium on molecular biology of influenza and hepatitis, Institute of Virology, Moscow,
USSR.
Sept 1987 - International Symposium of Virology, Edmonton, Canada
April 1989 - Society for General Microbiology/Biochemical Society symposium on Biochemical Aspects
of Antiviral Drugs and Vaccines. Cambridge, England.
Sept. 1992 - Approaches to control of influenza, Courcheval, France.
Feb. 1993 - Replication of negative strand viruses. Madrid, Spain.
Sept. 1994 - Negative Strand Virus Meeting, Estoril, Portugal
May, 1996 - Options for Control of Influenza, Cairns, Australia.
October, 1996 - International Symposium on Molecular Virology, Xi'an, China.
September 1997 - Negative Strand Virus Meeting, Dublin, Ireland
December 1997 - Neuraminidase Inhibitors, London, England
August 1999 – International Congress of Virology, Sydney, Australia (Stephen Stray gave the talk)
June 2000 – Negative Strand Virus Meeting, Quebec City, Canada (poster)
Sept 2000 – “Options for the control of influenza IV” Crete (and workshop chair)
April 2001 – The Origin and Control of Pandemic Influenza, London, England (roundtable chair)
June 2002 – Genome-based Pathogen Biology, Sanger Center, Cambridge England (poster)
October 2003 - Options for the control of Influenza V. Okinawa, Japan
June 2006 – Negative Strand Virus meeting, Salamanca, Spain.
June 2007 – Workshop Chair, Options for the Control of Influenza V, Toronto, Canada.
July 2007 – Plenary speaker, Australian Society for Microbiology annual meeting, Adelaide, Australia.
September 2008 – Overview speaker, WHO Workshop on Neuraminidase, Vilamoura, Portugal
May 2011 – Keystone Symposium on Pathogenesis of Influenza, Hong Kong
September 2011 – Workshop speaker, ESWI meeting, Malta
6

Gillian M. Air
Invited Speaker: National 1995– present
January 1995 – Keystone: Molecular Aspects of Viral Immunity
June 1996 – FASEB Virus Assembly meeting, Vermont
July 1997 – Workshop Convener, American Society for Virology
September 1997 - Amer. Chemical Society Symposium, Las Vegas; Influenza Inhibitors
March 1998 – Viropharma Inc., Pennsylvania
May 1998 – Oklahoma Medical Research Foundation
June 1998 – Molecular Biology of Negative Strand Viruses, Chicago.
March 1999 – Dept. Chemistry, Wichita State University, KS.
March 2000 – Dept Physics, Oklahoma State University, Stillwater
December 2000 –NCI Symposium “Understanding Antiviral Drug Resistance” Chantilly, Virginia
November 2002 – Student Affiliates of the American Chemical Society Bioethics Panel, OU Norman.
June 2004 – Workshop on Cell Biology and replication of Negative Strand Viruses, Evanston, Ill.
January 2005 – OMRF Structural Biology Group
Feb 2005 – Dept Microbiology, Oklahoma State University, Stillwater
April 2005 – Nebraska Center for Virology, Univ. Nebraska, Lincoln
April 2006 – Key Speaker, Sitlington Infectious Diseases Symposium, Oklahoma State University
October 2006 – Dyax Inc, Boston, MA
February 2007 – Emory University, Atlanta GA
August 2007 – FDA, Bethesda MD
September 2007 – Negative Strand RNA viruses 2007, Northwestern University, IL.
November 2007 – Glycobiology Society Satellite Meeting, Boston, MA.
June, 2008 – Immunobiology and Pathogenesis of Influenza, Atlanta, GA.
October, 2008 – NIAID Workshop on Immune Function & Biodefense in Children, Elderly and
Immunocompromised Populations. Seattle, WA.
December 2008 – Chair, NIGMS Workshop on Glycan Arrays, Bethesda, MD.
March 2009 – CFG Workshop on Glycan Arrays, La Jolla, CA.
March 2009 – ACS National Meeting Symposium on Carbohydrate Sensors, Salt Lake City
September 2009 – Westminster College, Fulton, MO. Symposium on “Global Health – Who Cares?”.
Influenza: approaches to control a global disease that keeps changing.
September 2009 – Philadelphia. NIAID Workshop on Immune Function & Biodefense in Children,
Elderly and Immunocompromised Populations.
October 2009 – NIGMS Workshop on Leveraging Glycan Array Screens with Biological, Computational
and Structural Data, Bethesda. Chair of panel discussion on Glycan Arrays
April 2010 – Indiana University “Antigenic and functional properties of the surface glycoproteins of
influenza virus: trying to keep up with moving targets”.
September 2010 – NIGMS Glycan Array workshop Emory Univ.
October, 2010 – seminar, College of Veterinary Health, OSU, Stillwater
January 2012 – seminar Baylor College of Medicine
March 2012 – invited speaker, NIAID meeting on pandemic vaccines, Bethesda MD
June 2012 – Plenary speaker, NIH Glycosciences meeting, Bethesda, MD
October 2012 – seminar speaker Univ Kansas, Lawrence
Other presentations (recent)
July 2002 – American Society for Virology, Lexington KY. 2 posters, one talk
February 2003 – AAAS Annual Meeting, Denver CO. Poster.
March 2003 – Seminar, Dept. Biochemistry & Molecular Biology, OUHSC
August 2003 – 2 nd Orthomyxovirus International Conference. Upma Gulati oral presentation
July 2004 American Society for Virology. Oral presentations by Upma Gulati and Janis Lee. Chair of
Orthomyxovirus workshop
7

Gillian M. Air
November 2004 - Joint US-Japan Glycobiology meeting, Honolulu. Poster presentation.
July 2005 - 3rd Orthomyxovirus Research conference, Cambridge, England. Upma Gulati presented
poster
July 2006 – American society for Virology, Madison Wisconsin. Oral presentations (G. Air, K. Kumari)
and Workshop chair.
November 2006 – Glycobiology 2006: Shelly Gulati presented poster.
June, 2007 – Options for the Control of Influenza VI, Toronto, Canada. Oral presentation Shelly Gulati,
posters with Linda Thompson and William Hildebrand.
July 2007 – American Society for Virology. JingQi Feng poster presentation.
July 2008 - American Society for Virology. Workshop talk
September 2008 – European Influenza Conference, Vilamoura, Portugal. Workshop talk.
November 2008 – Mary Tappert poster presentation, Glycobiology Society meeting, Fort Worth, TX.
July 2009 – American Society for Virology, Vancouver, Canada. Workshop chair, Mary Tappert
Workshop talk, Lyuba Popova poster.
October 2009 – OUHSC Infectious Diseases Conference. Influenza Past, Present and Future.
November 2009 – Glycobiology Society meeting, San Diego. Poster.
December, 2009 – Oklahoma Molecular Virology Coalition seminar “Swine flu and other influenza
mysteries”
February, 2010 - OUHSC College of Pharmacy “Old and new strategies against influenza viruses”
July 2010 - Workshop Chair, ASV annual meeting, Bozeman, MT. Two student posters.
September, 2010. Poster at Options for the Control of Influenza, Hong Kong.
November 2011 – Oklahoma Academy of Science invited symposium speaker
Conferences Organized:
March 1985: "The immune recognition of protein antigens", at Banbury Center, Cold Spring Harbor
Laboratory, New York. Funded by NSF (P.I. Gillian Air) and the Australian Department of Science (P.I.
Graeme Laver) as a US–Australia Symposium. Also the Robertson Fund (Cold Spring Harbor
Laboratory) to assist participants from Europe.
February 1989: “Use of X-ray crystallography in the design of antiviral agents” in Kona, Hawaii.
Funded by NIH (P.I. Gillian Air), the Australian Department of Industry, Technology and Commerce
(P.I. Graeme Laver), the International Union of Biochemistry, the International Union of
Crystallography, and contributions from several pharmaceutical companies.
December 2008: “Glycan array data: what does it tell us and how do we interpret it?” in Bethesda, MD.
Funded by NIGMS (with Pamela Marino).
November, 2010: “Downstream Consequences of Glycan Binding by Viruses”. CFG/NIGMS, St Pete
Beach, Florida. http://glycomics.scripps.edu/PI2010.html
November 2011: “Glycan binding by eukaryotic pathogens”, CFG mini-symposium. Seattle WA.
Outreach:
TV documentaries
Canadian Broadcasting Corporation: “Getting to grips with La Grippe” April 1988.
Canadian Broadcasting Corporation: “Dead Heat”. First aired 3/4/99
Op-Ed article
Oklahoman “Bird Flu: sorting facts from fears” June 5, 2006
Talks:
8

Gillian M. Air
Oklahoma Association of County Commissioners “Bird Flu” July 19, 2006
Tuesday Study Club, Nicholls Hills “Bird flu and human flu” March 6, 2007
Other:
“Cool jobs” article, Oklahoman 11-25-07. Channel 5 news interview 11-26-07
Channel 5 news, January & February 2008
November 2008 OCAST “Oklahoma Innovations” radio show.
Channel 5 morning news and Channel 52 news Jan 2009.
April 2009: several comments on swine flu. TV, Oklahoman
Jan 2013: Comments in The Oklahoman on the history of influenza pandemics
UNIVERSITY ADMINISTRATIVE ACTIVITIES
University of Alabama at Birmingham:
Molecular Cell Biology Graduate Committee, 1982 – 1985.
Microbiology Seminar Committee, 1983 – 1986, 1990 – 92.
Fermentation Facility Advisory Committee, November 1983 – 1985.
Chair, Microbiology Dept. Molecular Genetics Search Committee, 1984 – 1986.
Microbiology Department Executive Committee, 1985.
Director, UAB Cancer Center Protein Analysis & Peptide Synthesis Core Facility. 1985 – 1995.
CMB curriculum committee 1987 – 1988
Distinguished Faculty Lecturer Committee, 1988 – 89
Dept. Microbiology Promotions Committee, 1994
Southern Research Institute Biosafety Committee 1993-1996
CMB Graduate Program Steering Committee, 1992 – 1996
Medical School Research Advisory Committee, 1994 – 1996
Ph.D. Programs review committee, 1994
Graduate School Fellowship Committee, 1994 – 1996
UAB Faculty Senate, 1995 – 1996
Program Director: Graduate Training in Cell and Molecular Biology 1992–1996
Program Director: Basic Mechanisms in Virology 1992–1996
University of Oklahoma Health Sciences Center:
Department committees:
General Exam Committee 1996– 1998
Biophysical Chemistry Faculty Search Committee (chair) 1997–1998
Graduate Program Admissions committee 1997 – 2001
Adjunct Faculty Committee 1997 – 2000
Curriculum Revision committee (chair) 1997 - 1998
Student Recruitment committee 2001 - 2002
Senior Faculty Search Committee 2001
Director, Biochemistry & Molecular Biology Graduate Program 1997– 2006
Graduate Program Committee (Chair 1997 – 2006), 2010-present
Dentistry-Pharmacy course Review Committee (chair) 2004-5
Crystallography Search Committee 2004-5
Medical Biochemistry/Molecular Genetics Course Future Options Committee (chair) 2005
Seminar Committee 2007 – 2009
Space Committee (Chair) 2007 - present
Student Advisory Committee 1998 – 2000; 2007 - 2010
Dept Advisory Committee 1998 – present
Grant Plan Review Group 1998 – present
9

Gillian M. Air
Tenure and Promotion committee 2003 – present (Chair from 2007)
Medical Curriculum Committee 2010- present
Mentoring Committees - Blaine Mooers (Chair), Augie Pioszak
Graduate College Committees:
Curriculum Review Committee 1997 – 2000
SURE Selection Committee 1997 – 1998
OMRF-OUHSC Fellowship Selection Committee 1998
Provost Fellowship Committee 1998
Judge, Graduate Student Research Day 1997-present
Integrated Curriculum Committee 1998 – 2000 (Development of integrated, interdisciplinary first year
curriculum for the new Graduate Program in Biomedical Sciences [GPiBS]).
GPiBS Curriculum committee (chair) 2000 – 2001
GPiBS Admissions committee 2000 – 2001
GPiBS Student Advisory Committee 2001 – 2002 (Chair)
GPiBS Liaison 2003 – 2006
GPiBS Graduate Education & Curriculum Committee 2005 – present. Chair 2007-8.
Responsible Conduct in Research Committee 2007 – present
College of Nursing Graduate Program Review Committee 2011
Campus and local committees:
Ad Hoc, Institutional Biosafety Committee 1997
Presbyterian Foundation Grant Review Committee 1997, 2000
Medical Alumni Grant Review Committee 1997
Campus Stockroom committee 2000
Dept. Microbiol & Immunol. Virology Faculty Search committee, 2000, 2003
Oklahoma Medical Research Foundation: Search committee for Head of Structural Biology 2000.
Dept. Microbiol & Immunol. Virology Faculty Search committee, 2001
MD/Ph.D. Program Advisory Council 1999 – present
COBRA mentor, Dept Microbiology & Immunology 2004 – 2008 (Mike Sakalian and John West)
Virology Faculty Search Committees, Dept Microbiology & Immunology 2005 (Chair), 2008
College of Medicine Promotion and Tenure Committee 2006-2008. Chair 2007.
Molecular Biology Proteomics Core Facility Review Committee 2009
LCME Academic Environment sub-committee 2009 – 2010
Microbiology Chair search committee, 2010.
Institutional Biosafety Committee 2004 – present. Chair from 2010.
OU COBRE in Structural Biology, co-director and mentor 2012 - present
10

Gillian M. Air
GRANT SUPPORT:
Current:
NIH R01 AI050933 (PI Air, Gillian) 06/15/2008 – 05/31/2013
Human & mouse antibodies against influenza
Past Grant Support:
OCAST HR09-001 (PI Air, Gillian) 07-01-2009 – 06-30-2012
Role of glycans in pathogenesis of paramyxoviruses.
NIH-NIAID HHSN266200500026C: 09/30/2005 – 06/30/2011. PI Linda Thompson, OMRF. “Responses to
Influenza Vaccination in Systemic Lupus”. Subcontract to OUHSC, PI Gillian Air.
NIH-NIGMS subcontract for CFG Bridging grant “Glycan Array screening of a CFG Paradigm Glycan
Binding Protein: influenza H3 hemagglutinin. 3-1-2011 – 10-31-2011
NIH R01 AI-62950-01: 07/01/2005 – 06/30/2011 (no cost extension) "New Influenza A Neuraminidase
Inhibitors for Biodefense." PI Wayne Brouillette, UAB. Subcontract to OUHSC PI Gillian Air. Annual
subcontract direct costs $47,782.
NIH-NIAID HHS N266200400027C 4/01/04 - 3/31/09. “Direct Epitope Identification & Validation”. Large
scale antibody and T cell epitope discovery program for Biodefense PI William Hildebrand, coinvestigator
Air. Annual direct costs ~$60,000
NIH R01 AI-18203-22: 04/01/1982 – 11/30/2008. "Glycoconjugates in viral pathogenesis". Principal
Investigator: Gillian Air. Annual direct costs $200,000.
NIH R01 AI-50933-04: 08/01/2003 – 01/31/2008 (no cost extension). “Human & mouse antibodies against
influenza virus”. Annual direct costs $225,000.
Dyax Corp. Screening of an antibody library, $15,000, 2005-06.
NIH R21 AI-18203-19: 9/30/2001 – 12/01/2002. "Glycoconjugates in viral pathogenesis". Principal
Investigator: Gillian Air. Annual direct costs $200,000.
NIH R21 AI-50933 9/15/2002 – 9/14/2003. “Human & mouse antibodies against influenza virus”. Direct
costs $225,000
NIH R01 (R37 MERIT award) AI-19084-19: April 1 1983 – March 31, 2002. "Structure of antigenic sites on
influenza virus proteins". Principal Investigator: Gillian Air. Final year (-19) Direct Costs: $213,904.
NIH R01 AI-31888-09: Design of influenza virus neuraminidase inhibitors. Principal Investigator: Wayne
Brouillette (UAB). Subcontract (G. Air) annual direct costs $29,891. Ended 8/31/01.
R.W. Johnson Pharmaceutical Research Institute. “Sequencing HA and NA genes of drug-resistant
viruses” P.I. Gillian Air. Period: March 1, 1999 – February 29, 2000. Total direct costs: $7,400
NIH T32 GM-08111: Dec 1, 1992– June 30, 2001. Predoctoral Training in Cell and Molecular Biology.
Director Gillian Air until departure from UAB.
NIH T32 AI-07150: July 1, 1993 – June 30, 1998. Basic Mechanisms in Virology Training Grant (6 predoc,
4 postdoc). Director Gillian Air until departure from UAB.
Biocryst Pharmaceuticals, Inc. Jan 1, 1995 – June 30, 1996. “Biocryst/UAB Neuraminidase Inhibitors”. PI’s
Gillian Air, Wayne Brouillette, Ming Luo. Total Costs: $600,000. Grant not transferable to OUHSC.
NIH P30 CA-13148: March 1 1985 – February 28, 1995. UAB Cancer Center Core Support Grant.
Principal Investigator Albert F. LoBuglio. Subproject: Core Facility for protein analysis and peptide
synthesis, Director, Gillian Air.
11

Gillian M. Air
NIH R01 AI 26718 Sept 1 1987 – Aug 31 1993. “Structure and activity of influenza B neuraminidases”.
P.I. Gillian Air
NIH R13 AI 27040 “Workshop on Antiviral Design using X-ray crystallography” P.I. Gillian Air. 12/1/89 –
11/30/90
NIH S10 RR 04064 April 1 1988 – March 31 1989. “Protein Sequencing & Analysis Equipment”. P.I.
Gillian Air.
NSF INT-8320437 July 1, 1984 – December 31, 1984. “US–Australia symposium on Immune
Recognition of Protein Antigens". Principal Investigator Gillian Air.
NIH AI-15343: January 1 1979 – June 30, 1982. "Protein and RNA sequences of influenza virus
variants". Principal Investigator: Gillian Air.
Patent:
Air, G. M., Brouillette, W. J. and Luo, M. Inhibitors of influenza virus neuraminidase and methods of
making and using the same. (issued 1995).
12

Gillian M. Air
PUBLICATIONS
Journal Articles
1. Archer GT, Air G, Jackas M, Morell DB. Studies on Rat Eosinophil Peroxidase. Biochim Biophys
Acta. 1965;99:96-101. Epub 1965/04/26. PubMed PMID: 14325958.
2. Archer GT, Barker A, Air G, McGovern VJ. Eosinophilia in rats infected with Amplicaecum robertsi.
Aust J Exp Biol Med Sci. 1966;44(1):45-56. Epub 1966/02/01. PubMed PMID: 5913713.
3. Air GM, Thompson EOP. Studies on marsupial proteins, II. Amino acid sequence of the β-chain of
haemoglobin from the grey kangaroo, Macropus giganteus. Aust J Biol Sci. 1969;22:1437-54.
4. Thompson EO, Hosken R, Air GM. Studies on marsupial proteins. I. Polymorphism of haemoglobin of
the grey kangaroo, Macropus giganteus. Aust J Biol Sci. 1969;22(2):449-62. Epub 1969/04/01.
PubMed PMID: 5793323.
5. Air GM, Thompson EO. Studies on marsupial proteins. IV. Amino acid sequence of myoglobin from the
red kangaroo, Megaleia rufa. Aust J Biol Sci. 1971;24(1):75-95. Epub 1971/02/01. PubMed PMID:
5553675.
6. Air GM, Thompson EO, Richardson BJ, Sharman GB. Amino-acid sequences of kangaroo myoglobin
and haemoglobin and the date of marsupial-eutherian divergence. Nature. 1971;229(5284):391-4.
Epub 1971/02/05. PubMed PMID: 4926989.
7. Thompson EO, Air GM. Studies on marsupial proteins. VI. Evolutionary changes of beta-globins of the
macropodidae and the amino acid sequence of beta-globin from Potorous tridactylus. Aust J Biol Sci.
1971;24(6):1199-217. Epub 1971/12/01. PubMed PMID: 5005884.
8. Air GM, Bridgen J. Correlation between a coat protein amino-terminal sequence and a ribosomebinding
DNA sequence from phiX 174. Nat New Biol. 1973;241(106):40-1. Epub 1973/01/10. PubMed
PMID: 4572839.
9. Air GM, Harris JI. DNA-dependent RNA polymerase from the thermophilic bacterium Thermus
aquaticus. FEBS Lett. 1974;38(3):277-81. Epub 1974/01/15. PubMed PMID: 4604362.
10. Air GM, Blackburn EH, Sanger F, Coulson AR. The nucleotide and amino acid sequences of the N (5')
terminal region of gene G of bacteriophage phiphiX 174. J Mol Biol. 1975;96(4):703-19. Epub
1975/08/25. PubMed PMID: 1081600.
11. Air GM. Amino acid sequences from the gene F (capsid) protein of bacteriophage phiX174. J Mol
Biol. 1976;107(4):433-43. Epub 1976/11/15. PubMed PMID: 794486.
12. Air GM, Blackburn EH, Coulson AR, Galibert F, Sanger F, Sedat JW, Ziff EB. Gene F of bacteriophage
phiX174. Correlation of nucleotide sequences from the DNA and amino acid sequences from the gene
product. J Mol Biol. 1976;107(4):445-58. Epub 1976/11/15. PubMed PMID: 1088826.
13. Air GM, Sanger F, Coulson AR. Nucleotide and amino acid sequences of gene G of omegaX174. J
Mol Biol. 1976;108(3):519-33. Epub 1976/12/15. PubMed PMID: 1088827.
14. Barrell BG, Air GM, Hutchison CA, 3rd. Overlapping genes in bacteriophage phiX174. Nature.
1976;264(5581):34-41. Epub 1976/11/04. PubMed PMID: 1004533.
15. Ladner R, Air GM, Fogg JH. A correction to the sequence of the alpha chains of horse haemoglobin. J
Mol Biol. 1976;103(3):675-7. Epub 1976/05/25. PubMed PMID: 940162.
16. Sanger F, Air GM, Barrell BG, Brown NL, Coulson AR, Fiddes CA, Hutchison CA, Slocombe PM,
Smith M. Nucleotide sequence of bacteriophage phi X174 DNA. Nature. 1977;265(5596):687-95.
Epub 1977/02/24. PubMed PMID: 870828.
17. Smith M, Brown NL, Air GM, Barrell BG, Coulson AR, Hutchison CA, 3rd, Sanger F. DNA sequence at
the C termini of the overlapping genes A and B in bacteriophage phi X174. Nature.
1977;265(5596):702-5. Epub 1977/02/24. PubMed PMID: 859575.
18. Air GM, Coulson AR, Fiddes JC, Friedmann T, Hutchison CA, 3rd, Sanger F, Slocombe PM, Smith AJ.
Nucleotide sequence of the F protein coding region of bacteriophage phiX174 and the amino acid
sequence of its product. J Mol Biol. 1978;125(2):247-54. Epub 1978/10/25. PubMed PMID: 731694.
19. Sanger F, Coulson AR, Friedmann T, Air GM, Barrell BG, Brown NL, Fiddes JC, Hutchison CA, 3rd,
Slocombe PM, Smith M. The nucleotide sequence of bacteriophage phiX174. J Mol Biol.
1978;125(2):225-46. Epub 1978/10/25. PubMed PMID: 731693.
13

Gillian M. Air
20. Air GM. Nucleotide sequence coding for the "signal peptide" and N terminus of the hemagglutinin from
an asian (H2N2) strain of influenza virus. Virology. 1979;97(2):468-72. Epub 1979/09/01. PubMed
PMID: 473601.
21. Air GM. Rapid DNA sequence analysis. CRC Crit Rev Biochem. 1979;6(1):1-33. Epub 1979/01/01.
PubMed PMID: 88296.
22. Both GW, Air GM. Nucleotide sequence coding for the N-terminal region of the matrix protein influenza
virus. Eur J Biochem. 1979;96(2):363-72. Epub 1979/05/15. PubMed PMID: 572297.
23. Laver WG, Air GM, Webster RG, Gerhard W, Ward CW, Dopheide TA. Antigenic drift in type A
influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with
monoclonal hybridoma antibodies. Virology. 1979;98(1):226-37. Epub 1979/10/15. PubMed PMID:
90425.
24. Laver WG, Gerhard W, Webster RG, Frankel ME, Air GM. Antigenic drift in type A influenza virus:
peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal
antibodies. Proc Natl Acad Sci U S A. 1979;76(3):1425-9. Epub 1979/03/01. PubMed PMID: 86990;
PubMed Central PMCID: PMC383264.
25. Air GM, Hackett JA. Gene 8 of influenza virus: sequences of cDNA transcribed from the 3' ends of viral
RNA of influenza A and B strains. Virology. 1980;103(2):291-8. Epub 1980/06/01. PubMed PMID:
7385583.
26. Air GM, Laver WG, Webster RG. Towards a universal influenza vaccine. Prog Clin Biol Res.
1980;47:193-215. Epub 1980/01/01. PubMed PMID: 6163156.
27. Blok J, Air GM. Comparative nucleotide sequences at the 3' end of the neuraminidase gene from
eleven influenza type A viruses. Virology. 1980;107(1):50-60. Epub 1980/11/01. PubMed PMID:
7445434.
28. Laver WG, Air GM, Dopheide TA, Ward CW. Amino acid sequence changes in the haemagglutinin of
A/Hong Kong (H3N2) influenza virus during the period 1968--77. Nature. 1980;283(5746):454-7. Epub
1980/01/31. PubMed PMID: 6153236.
29. Laver WG, Air GM, Webster RG. NIAID News. Summary of a meeting on structure and variation in
influenza viruses. J Infect Dis. 1980;142(3):465-71. Epub 1980/09/01. PubMed PMID: 6160186.
30. Laver WG, Air GM, Webster RG, Gerhard W, Ward CW, Dopheide TA. The mechanism of antigenic
drift in influenza virus: sequence changes in the haemagglutinin of variants selected with monoclonal
hybridoma antibodies. Philos Trans R Soc Lond B Biol Sci. 1980;288(1029):313-26. Epub
1980/02/25. PubMed PMID: 6103548.
31. Webster RG, Laver WG, Air GM, Ward C, Gerhard W, van Wyke KL. The mechanism of antigenic drift
in influenza viruses: analysis of Hong Kong (H3N2) variants with monoclonal antibodies to the
hemagglutinin molecule. Ann N Y Acad Sci. 1980;354:142-61. Epub 1980/01/01. PubMed PMID:
6164328.
32. Air GM. Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.
Proc Natl Acad Sci U S A. 1981;78(12):7639-43. Epub 1981/12/01. PubMed PMID: 6174976;
PubMed Central PMCID: PMC349324.
33. Hall RM, Air GM. Variation in nucleotide sequences coding for the N-terminal regions of the matrix and
nonstructural proteins of influenza A viruses. J Virol. 1981;38(1):1-7. Epub 1981/04/01. PubMed
PMID: 7241645; PubMed Central PMCID: PMC171118.
34. Laver WG, Air GM, Webster RG. Antigenicity of influenza virus hemagglutinin following chemical
modification. Virology. 1981;111(2):538-48. Epub 1981/06/01. PubMed PMID: 6787797.
35. Laver WG, Air GM, Webster RG. Mechanism of antigenic drift in influenza virus. Amino acid sequence
changes in an antigenically active region of Hong Kong (H3N2) influenza virus hemagglutinin. J Mol
Biol. 1981;145(2):339-61. Epub 1981/01/15. PubMed PMID: 6167724.
36. Blok J, Air GM. Sequence variation at the 3' end of the neuraminidase gene from 39 influenza type A
viruses. Virology. 1982;121(2):211-29. Epub 1982/09/01. PubMed PMID: 6927853.
37. Blok J, Air GM. Variation in the membrane-insertion and "stalk" sequences in eight subtypes of
influenza type A virus neuraminidase. Biochemistry (Mosc). 1982;21(17):4001-7. Epub 1982/08/17.
PubMed PMID: 6896994.
38. Blok J, Air GM. Block deletions in the neuraminidase genes from some influenza A viruses of the N1
subtype. Virology. 1982;118(1):229-34. Epub 1982/04/15. PubMed PMID: 7080440.
14

Gillian M. Air
39. Blok J, Air GM, Laver WG, Ward CW, Lilley GG, Woods EF, Roxburgh CM, Inglis AS. Studies on the
size, chemical composition, and partial sequence of the neuraminidase (NA) from type A influenza
viruses show that the N-terminal region of the NA is not processed and serves to anchor the NA in the
viral membrane. Virology. 1982;119(1):109-21. Epub 1982/05/01. PubMed PMID: 7072153.
40. Hinshaw VS, Air GM, Gibbs AJ, Graves L, Prescott B, Karunakaran D. Antigenic and genetic
characterization of a novel hemagglutinin subtype of influenza A viruses from gulls. J Virol.
1982;42(3):865-72. Epub 1982/06/01. PubMed PMID: 7097861; PubMed Central PMCID:
PMC256920.
41. Laver WG, Air GM, Webster RG, Markoff LJ. Amino acid sequence changes in antigenic variants of
type A influenza virus N2 neuraminidase. Virology. 1982;122(2):450-60. Epub 1982/10/30. PubMed
PMID: 6183823.
42. Webster RG, Laver WG, Air GM, Schild GC. Molecular mechanisms of variation in influenza viruses.
Nature. 1982;296(5853):115-21. Epub 1982/03/11. PubMed PMID: 6174870.
43. Hinshaw VS, Air GM, Schild GC, Newman RW. Characterization of a novel haemagglutinin subtype
(H13) of influenza A viruses from gulls. Bull World Health Organ. 1983;61(4):677-9. Epub
1983/01/01. PubMed PMID: 6194911; PubMed Central PMCID: PMC2536146.
44. Newton SE, Air GM, Webster RG, Laver WG. Sequence of the hemagglutinin gene of influenza virus
A/Memphis/1/71 and previously uncharacterized monoclonal antibody-derived variants. Virology.
1983;128(2):495-501. Epub 1983/07/30. PubMed PMID: 6193634.
45. Hovanec DL, Air GM. Antigenic structure of the hemagglutinin of influenza virus B/Hong Kong/8/73 as
determined from gene sequence analysis of variants selected with monoclonal antibodies. Virology.
1984;139(2):384-92. Epub 1984/12/01. PubMed PMID: 6083660.
46. Laver WG, Colman PM, Webster RG, Hinshaw VS, Air GM. Influenza virus neuraminidase with
hemagglutinin activity. Virology. 1984;137(2):314-23. Epub 1984/09/01. PubMed PMID: 6485252.
47. Lentz MR, Air GM, Laver WG, Webster RG. Sequence of the neuraminidase gene of influenza virus
A/Tokyo/3/67 and previously uncharacterized monoclonal variants. Virology. 1984;135(1):257-65.
Epub 1984/05/01. PubMed PMID: 6203216.
48. Air GM, Els MC, Brown LE, Laver WG, Webster RG. Location of antigenic sites on the threedimensional
structure of the influenza N2 virus neuraminidase. Virology. 1985;145(2):237-48. Epub
1985/09/01. PubMed PMID: 2411049.
49. Air GM, Ritchie LR, Laver WG, Colman PM. Gene and protein sequence of an influenza
neuraminidase with hemagglutinin activity. Virology. 1985;145(1):117-22. Epub 1985/08/01. PubMed
PMID: 4013081.
50. Els MC, Air GM, Murti KG, Webster RG, Laver WG. An 18-amino acid deletion in an influenza
neuraminidase. Virology. 1985;142(2):241-7. Epub 1985/04/30. PubMed PMID: 4060573.
51. Air GM, Laver WG. The molecular basis of antigenic variation in influenza virus. Adv Virus Res.
1986;31:53-102. Epub 1986/01/01. PubMed PMID: 2428216.
52. Dale B, Brown R, Miller J, White RT, Air GM, Cordell B. Nucleotide and deduced amino acid sequence
of the influenza neuraminidase genes of two equine serotypes. Virology. 1986;155(2):460-8. Epub
1986/12/01. PubMed PMID: 3788060.
53. Lentz MR, Air GM. Loss of enzyme activity in a site-directed mutant of influenza neuraminidase
compared to expressed wild-type protein. Virology. 1986;148(1):74-83. Epub 1986/01/15. PubMed
PMID: 2417413.
54. Tulloch PA, Colman PM, Davis PC, Laver WG, Webster RG, Air GM. Electron and X-ray diffraction
studies of influenza neuraminidase complexed with monoclonal antibodies. J Mol Biol.
1986;190(2):215-25. Epub 1986/07/20. PubMed PMID: 3795268.
55. Air GM, Lentz MR, Ritchie LR, Vai K, Hamilton AM. [Expression and mutagenesis of genes coding for
protein synthesis in the influenza virus]. Vopr Virusol. 1987;32(1):44-51. Epub 1987/01/01. PubMed
PMID: 3033905.
56. Air GM, Webster RG, Colman PM, Laver WG. Distribution of sequence differences in influenza N9
neuraminidase of tern and whale viruses and crystallization of the whale neuraminidase complexed
with antibodies. Virology. 1987;160(2):346-54. Epub 1987/10/01. PubMed PMID: 3660585.
57. Baker AT, Varghese JN, Laver WG, Air GM, Colman PM. Three-dimensional structure of
neuraminidase of subtype N9 from an avian influenza virus. Proteins. 1987;2(2):111-7. Epub
15

Gillian M. Air
1987/01/01. doi: 10.1002/prot.340020205. PubMed PMID: 3447170.
58. Colman PM, Laver WG, Varghese JN, Baker AT, Tulloch PA, Air GM, Webster RG. Three-dimensional
structure of a complex of antibody with influenza virus neuraminidase. Nature. 1987;326(6111):358-
63. Epub 1987/03/01. doi: 10.1038/326358a0. PubMed PMID: 2436051.
59. Lentz MR, Webster RG, Air GM. Site-directed mutation of the active site of influenza neuraminidase
and implications for the catalytic mechanism. Biochemistry (Mosc). 1987;26(17):5351-8. Epub
1987/08/25. PubMed PMID: 3314986.
60. Ritchie LR, Webster RG, Laver WG, Air GM. Heterogeneity of neuraminidase genetic information in an
H1N2 reassortant influenza virus [X-7 (F1)]. Brief report. Arch Virol. 1987;96(3-4):303-8. Epub
1987/01/01. PubMed PMID: 3502714.
61. Webster RG, Air GM, Metzger DW, Colman PM, Varghese JN, Baker AT, Laver WG. Antigenic
structure and variation in an influenza virus N9 neuraminidase. J Virol. 1987;61(9):2910-6. Epub
1987/09/01. PubMed PMID: 3612957; PubMed Central PMCID: PMC255818.
62. Wei X, Els MC, Webster RG, Air GM. Effects of site-specific mutation on structure and activity of
influenza virus B/Lee/40 neuraminidase. Virology. 1987;156(2):253-8. Epub 1987/02/01. PubMed
PMID: 3811237.
63. Bossart PJ, Babu YS, Cook WJ, Air GM, Laver WG. Crystallization and preliminary X-ray analyses of
two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40. J Biol Chem.
1988;263(13):6421-3. Epub 1988/05/05. PubMed PMID: 3360786.
64. Laver WG, Luo M, Bossart PJ, Babu YS, Smith C, Accavitti MA, Tulloch PA, Air GM. Crystallization
and preliminary X-ray analysis of type B influenza virus neuraminidase complexed with antibody Fab
fragments. Virology. 1988;167(2):621-4. Epub 1988/12/01. PubMed PMID: 3201756.
65. Air GM, Laver WG. The neuraminidase of influenza virus. Proteins. 1989;6(4):341-56. Epub
1989/01/01. doi: 10.1002/prot.340060402. PubMed PMID: 2482974.
66. Air GM, Laver WG, Webster RG, Els MC, Luo M. Antibody recognition of the influenza virus
neuraminidase. Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:247-55. Epub 1989/01/01.
PubMed PMID: 2484161.
67. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D,
Tulip WR, et al. Conformations of immunoglobulin hypervariable regions. Nature.
1989;342(6252):877-83. Epub 1989/12/21. doi: 10.1038/342877a0. PubMed PMID: 2687698.
68. Colman PM, Tulip WR, Varghese JN, Tulloch PA, Baker AT, Laver WG, Air GM, Webster RG. Threedimensional
structures of influenza virus neuraminidase-antibody complexes. Philos Trans R Soc
Lond B Biol Sci. 1989;323(1217):511-8. Epub 1989/06/12. PubMed PMID: 2569208.
69. Els MC, Laver WG, Air GM. Sialic acid is cleaved from glycoconjugates at the cell surface when
influenza virus neuraminidases are expressed from recombinant vaccinia viruses. Virology.
1989;170(1):346-51. Epub 1989/05/01. PubMed PMID: 2718386.
70. Laver WG, Air GM. The molecular basis of variation in influenza virus. Patient Management.
1989;13:13-29.
71. Tulip WR, Varghese JN, Webster RG, Air GM, Laver WG, Colman PM. Crystal structures of
neuraminidase-antibody complexes. Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:257-63. Epub
1989/01/01. PubMed PMID: 2484162.
72. Air GM, Gibbs AJ, Laver WG, Webster RG. Evolutionary changes in influenza B are not primarily
governed by antibody selection. Proc Natl Acad Sci U S A. 1990;87(10):3884-8. Epub 1990/05/01.
PubMed PMID: 2378639; PubMed Central PMCID: PMC54008.
73. Air GM, Laver WG, Luo M, Stray SJ, Legrone G, Webster RG. Antigenic, sequence, and crystal
variation in influenza B neuraminidase. Virology. 1990;177(2):578-87. Epub 1990/08/01. PubMed
PMID: 1695410.
74. Air GM, Laver WG, Webster RG. Mechanism of antigenic variation in an individual epitope on
influenza virus N9 neuraminidase. J Virol. 1990;64(12):5797-803. Epub 1990/12/01. PubMed PMID:
1700825; PubMed Central PMCID: PMC248733.
75. Laver WG, Air GM, Webster RG, Smith-Gill SJ. Epitopes on protein antigens: misconceptions and
realities. Cell. 1990;61(4):553-6. Epub 1990/05/18. PubMed PMID: 1693095.
76. Lin YJ, Luo M, Laver WG, Air GM, Smith CD, Webster RG. New crystalline forms of neuraminidase of
16

Gillian M. Air
type B human influenza virus. J Mol Biol. 1990;214(3):639-40. Epub 1990/08/05. PubMed PMID:
2388263.
77. Wu Q, Lahti JM, Air GM, Burrows PD, Cooper MD. Molecular cloning of the murine BP-1/6C3 antigen:
a member of the zinc-dependent metallopeptidase family. Proc Natl Acad Sci U S A. 1990;87(3):993-
7. Epub 1990/02/01. PubMed PMID: 1689065; PubMed Central PMCID: PMC53396.
78. Nuss JM, Air GM. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9
into an N2 neuraminidase background. Virology. 1991;183(2):496-504. Epub 1991/08/01. PubMed
PMID: 1853557.
79. Luo M, Laver WG, Air G. Unusual diffraction of type B influenza virus neuraminidase crystals. Acta
Crystallogr A. 1992;48 ( Pt 3):263-6. Epub 1992/05/01. PubMed PMID: 1605932.
80. Bossart-Whitaker P, Carson M, Babu YS, Smith CD, Laver WG, Air GM. Three-dimensional structure
of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl
neuraminic acid. J Mol Biol. 1993;232(4):1069-83. Epub 1993/08/20. doi: 10.1006/jmbi.1993.1461.
PubMed PMID: 8371267.
81. Liu C, Air GM. Selection and characterization of a neuraminidase-minus mutant of influenza virus and
its rescue by cloned neuraminidase genes. Virology. 1993;194(1):403-7. Epub 1993/05/01. doi:
10.1006/viro.1993.1276. PubMed PMID: 8480427.
82. Nuss JM, Whitaker PB, Air GM. Identification of critical contact residues in the NC41 epitope of a
subtype N9 influenza virus neuraminidase. Proteins. 1993;15(2):121-32. Epub 1993/02/01. doi:
10.1002/prot.340150204. PubMed PMID: 7680132.
83. Janakiraman MN, White CL, Laver WG, Air GM, Luo M. Structure of influenza virus neuraminidase
B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the
catalytic mechanism. Biochemistry (Mosc). 1994;33(27):8172-9. Epub 1994/07/12. PubMed PMID:
8031750.
84. Nuss JM, Air GM. Defining the requirements for an antibody epitope on influenza virus neuraminidase:
how tolerant are protein epitopes? J Mol Biol. 1994;235(2):747-59. Epub 1994/01/14. doi:
10.1006/jmbi.1994.1025. PubMed PMID: 7507170.
85. Zhang H, Air GM. Expression of functional influenza virus A polymerase proteins and template from
cloned cDNAS in recombinant vaccinia virus infected cells. Biochem Biophys Res Commun.
1994;200(1):95-101. Epub 1994/04/15. doi: 10.1006/bbrc.1994.1419. PubMed PMID: 8166749.
86. Air GM, Laver WG. Red cells bound to influenza virus N9 neuraminidase are not released by the N9
neuraminidase activity. Virology. 1995;211(1):278-84. Epub 1995/08/01. doi: 10.1006/viro.1995.1401.
PubMed PMID: 7645221.
87. Jedrzejas MJ, Luo M, Singh S, Brouillette WJ, Air GM. 4-(Acetylamino)-3-hydroxy-5-nitrobenzoic acid.
Acta Crystallogr C. 1995;51 ( Pt 9):1910-2. Epub 1995/09/15. PubMed PMID: 7576370.
88. Jedrzejas MJ, Singh S, Brouillette WJ, Air GM, Luo M. A strategy for theoretical binding constant, Ki,
calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of
influenza virus neuraminidase. Proteins. 1995;23(2):264-77. Epub 1995/10/01. doi:
10.1002/prot.340230215. PubMed PMID: 8592707.
89. Jedrzejas MJ, Singh S, Brouillette WJ, Laver WG, Air GM, Luo M. Structures of aromatic inhibitors of
influenza virus neuraminidase. Biochemistry (Mosc). 1995;34(10):3144-51. Epub 1995/03/14.
PubMed PMID: 7880809.
90. Liu C, Eichelberger MC, Compans RW, Air GM. Influenza type A virus neuraminidase does not play a
role in viral entry, replication, assembly, or budding. J Virol. 1995;69(2):1099-106. Epub 1995/02/01.
PubMed PMID: 7815489; PubMed Central PMCID: PMC188682.
91. Luo M, Jedrzejas MJ, Singh S, White CL, Brouillette WJ, Air GM, Laver WG. Benzoic acid inhibitors of
influenza virus neuraminidase. Acta Crystallogr D Biol Crystallogr. 1995;51(Pt 4):504-10. Epub
1995/07/01. doi: 10.1107/S0907444994011698. PubMed PMID: 15299837.
92. Rivera K, Thomas H, Zhang H, Bossart-Whitaker P, Wei X, Air GM. Probing the structure of influenza
B hemagglutinin using site-directed mutagenesis. Virology. 1995;206(2):787-95. Epub 1995/02/01.
doi: 10.1006/viro.1995.1001. PubMed PMID: 7856092.
93. Singh S, Jedrzejas MJ, Air GM, Luo M, Laver WG, Brouillette WJ. Structure-based inhibitors of
influenza virus sialidase. A benzoic acid lead with novel interaction. J Med Chem. 1995;38(17):3217-
25. Epub 1995/08/18. PubMed PMID: 7650674.
17

Gillian M. Air
94. Staschke KA, Colacino JM, Baxter AJ, Air GM, Bansal A, Hornback WJ, Munroe JE, Laver WG.
Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology.
1995;214(2):642-6. Epub 1995/12/20. doi: 10.1006/viro.1995.0078. PubMed PMID: 8553569.
95. White CL, Janakiraman MN, Laver WG, Philippon C, Vasella A, Air GM, Luo M. A sialic acid-derived
phosphonate analog inhibits different strains of influenza virus neuraminidase with different
efficiencies. J Mol Biol. 1995;245(5):623-34. Epub 1995/02/03. PubMed PMID: 7844831.
96. Colacino JM, Laver WG, Air GM. Selection of influenza A and B viruses for resistance to 4-guanidino-
Neu5Ac2en in cell culture. J Infect Dis. 1997;176 Suppl 1:S66-8. Epub 1997/08/01. PubMed PMID:
9240698.
97. Luo M, Air GM, Brouillette WJ. Design of aromatic inhibitors of influenza virus neuraminidase. J Infect
Dis. 1997;176 Suppl 1:S62-5. Epub 1997/08/01. PubMed PMID: 9240697.
98. Sudbeck EA, Jedrzejas MJ, Singh S, Brouillette WJ, Air GM, Laver WG, Babu YS, Bantia S, Chand P,
Chu N, Montgomery JA, Walsh DA, Luo M. Guanidinobenzoic acid inhibitors of influenza virus
neuraminidase. J Mol Biol. 1997;267(3):584-94. Epub 1997/04/04. doi: 10.1006/jmbi.1996.0885.
PubMed PMID: 9126840.
99. Yang P, Bansal A, Liu C, Air GM. Hemagglutinin specificity and neuraminidase coding capacity of
neuraminidase-deficient influenza viruses. Virology. 1997;229(1):155-65. Epub 1997/03/03. doi:
10.1006/viro.1996.8421. PubMed PMID: 9123857.
100. Bantia S, Ghate AA, Ananth SL, Babu YS, Air GM, Walsh GM. Generation and characterization of a
mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140. Antimicrob Agents
Chemother. 1998;42(4):801-7. Epub 1998/04/29. PubMed PMID: 9559786; PubMed Central PMCID:
PMC105545.
101. Ghate AA, Air GM. Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as
an aid to drug design. Eur J Biochem. 1998;258(2):320-31. Epub 1999/01/05. PubMed PMID:
9874196.
102. Pruett PS, Air GM. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase:
amino acid contacts on the antibody heavy chain. Biochemistry (Mosc). 1998;37(30):10660-70. Epub
1998/08/07. doi: 10.1021/bi9802059. PubMed PMID: 9692956.
103. Air GM, Ghate AA, Stray SJ. Influenza neuraminidase as target for antivirals. Adv Virus Res.
1999;54:375-402. Epub 1999/11/05. PubMed PMID: 10547680.
104. Atigadda VR, Brouillette WJ, Duarte F, Ali SM, Babu YS, Bantia S, Chand P, Chu N, Montgomery JA,
Walsh DA, Sudbeck EA, Finley J, Luo M, Air GM, Laver GW. Potent inhibition of influenza sialidase by
a benzoic acid containing a 2-pyrrolidinone substituent. J Med Chem. 1999;42(13):2332-43. Epub
1999/07/08. doi: 10.1021/jm980707k. PubMed PMID: 10395473.
105. Atigadda VR, Brouillette WJ, Duarte F, Babu YS, Bantia S, Chand P, Chu N, Montgomery JA, Walsh
DA, Sudbeck E, Finley J, Air GM, Luo M, Laver GW. Hydrophobic benzoic acids as inhibitors of
influenza neuraminidase. Bioorg Med Chem. 1999;7(11):2487-97. Epub 2000/01/13. PubMed PMID:
10632058.
106. Brouillette WJ, Atigadda VR, Luo M, Air GM, Babu YS, Bantia S. Design of benzoic acid inhibitors of
influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping. Bioorg Med Chem
Lett. 1999;9(14):1901-6. Epub 1999/08/18. PubMed PMID: 10450950.
107. Finley JB, Atigadda VR, Duarte F, Zhao JJ, Brouillette WJ, Air GM, Luo M. Novel aromatic inhibitors of
influenza virus neuraminidase make selective interactions with conserved residues and water
molecules in the active site. J Mol Biol. 1999;293(5):1107-19. Epub 1999/11/05. doi:
10.1006/jmbi.1999.3180. PubMed PMID: 10547289.
108. Ghate AA, Air GM. Influenza type B neuraminidase can replace the function of type A neuraminidase.
Virology. 1999;264(2):265-77. Epub 1999/11/24. doi: 10.1006/viro.1999.9936. PubMed PMID:
10562491.
109. Stray SJ, Cummings RD, Air GM. Influenza virus infection of desialylated cells. Glycobiology.
2000;10(7):649-58. Epub 2000/07/27. PubMed PMID: 10910970.
110. Stray SJ, Air GM. Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis.
Virus Res. 2001;77(1):3-17. Epub 2001/07/14. PubMed PMID: 11451482.
111. Gulati U, Hwang CC, Venkatramani L, Gulati S, Stray SJ, Lee JT, Laver WG, Bochkarev A, Zlotnick A,
Air GM. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
18

Gillian M. Air
J Virol. 2002;76(23):12274-80. Epub 2002/11/05. PubMed PMID: 12414967; PubMed Central PMCID:
PMC136895.
112. Lee JT, Air GM. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.
Virology. 2002;300(2):255-68. Epub 2002/09/28. PubMed PMID: 12350356.
113. Brouillette WJ, Bajpai SN, Ali SM, Velu SE, Atigadda VR, Lommer BS, Finley JB, Luo M, Air GM.
Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential
pyrrolidinone ring substituents. Bioorg Med Chem. 2003;11(13):2739-49. Epub 2003/06/06. PubMed
PMID: 12788348.
114. Lommer BS, Ali SM, Bajpai SN, Brouillette WJ, Air GM, Luo M. A benzoic acid inhibitor induces a
novel conformational change in the active site of Influenza B virus neuraminidase. Acta Crystallogr D
Biol Crystallogr. 2004;60(Pt 6):1017-23. Epub 2004/05/26. doi: 10.1107/S0907444904006225.
PubMed PMID: 15159560.
115. Wu W, Air GM. Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33
hemagglutinin bind to alpha2,8-linked sialic acid. Virology. 2004;325(2):340-50. Epub 2004/07/13. doi:
10.1016/j.virol.2004.05.013. PubMed PMID: 15246273.
116. Gulati U, Kumari K, Wu W, Keitel WA, Air GM. Amount and avidity of serum antibodies against native
glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine.
2005;23(11):1414-25. Epub 2005/01/22. doi: 10.1016/j.vaccine.2004.08.053. PubMed PMID:
15661391.
117. Gulati U, Wu W, Gulati S, Kumari K, Waner JL, Air GM. Mismatched hemagglutinin and neuraminidase
specificities in recent human H3N2 influenza viruses. Virology. 2005;339(1):12-20. Epub 2005/06/14.
doi: 10.1016/j.virol.2005.05.009. PubMed PMID: 15950996.
118. Lee JT, Air GM. Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal
antibody Mem5. Virology. 2006;345(2):424-33. Epub 2005/11/22. doi: 10.1016/j.virol.2005.10.014.
PubMed PMID: 16297424.
119. Venkatramani L, Bochkareva E, Lee JT, Gulati U, Graeme Laver W, Bochkarev A, Air GM. An
epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly
hydrated interface in the NA-antibody complex. J Mol Biol. 2006;356(3):651-63. Epub 2005/12/31.
doi: 10.1016/j.jmb.2005.11.061. PubMed PMID: 16384583.
120. Amonsen M, Smith DF, Cummings RD, Air GM. Human parainfluenza viruses hPIV1 and hPIV3 bind
oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian
influenza virus hemagglutinin. J Virol. 2007;81(15):8341-5. Epub 2007/05/25. doi: 10.1128/JVI.00718-
07. PubMed PMID: 17522226; PubMed Central PMCID: PMC1951310.
121. Gulati U, Keitel WA, Air GM. Increased antibodies against unfolded viral antigens in the elderly after
influenza vaccination. Influenza Other Respi Viruses. 2007;1(4):147-56. Epub 2008/05/07. doi:
10.1111/j.1750-2659.2007.00017.x. PubMed PMID: 18458742; PubMed Central PMCID:
PMC2367137.
122. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. Receptor binding specificity of recent
human H3N2 influenza viruses. Virol J. 2007;4:42. Epub 2007/05/11. doi: 10.1186/1743-422X-4-42.
PubMed PMID: 17490484; PubMed Central PMCID: PMC1876801.
123. Nicholls JM, Chan RW, Russell RJ, Air GM, Peiris JS. Evolving complexities of influenza virus and its
receptors. Trends Microbiol. 2008;16(4):149-57. Epub 2008/04/01. doi: 10.1016/j.tim.2008.01.008.
PubMed PMID: 18375125.
124. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms
C, James J, Air GM, Capra JD, Ahmed R, Wilson PC. Rapid cloning of high-affinity human monoclonal
antibodies against influenza virus. Nature. 2008;453(7195):667-71. PMC2515609.
125. Feng J, Gulati U, Zhang X, Keitel WA, Thompson DM, James JA, Thompson LF, Air GM. Antibody
quantity versus quality after influenza vaccination. Vaccine. 2009;27(45):6358-62. Epub 2009/10/21.
PMC2765411.
126. Gulati S, Smith DF, Air GM. Deletions of neuraminidase and resistance to oseltamivir may be a
consequence of restricted receptor specificity in recent H3N2 influenza viruses. Virol J. 2009;6:22.
Epub 2009/02/17. PMC2649058.
127. Wahl A, Schafer F, Bardet W, Buchli R, Air GM, Hildebrand WH. HLA class I molecules consistently
present internal influenza epitopes. Proc Natl Acad Sci U S A. 2009;106(2):540-5. Epub 2009/01/06.
19

Gillian M. Air
PMC2626739.
128. Air GM, Feng J, Chen T, Joachims ML, James JA, Thompson LF. Individual antibody and T cell
responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus. J
Clin Immunol. 2011;31(5):900-12. PMC3197711.
129. Crowe SR, Merrill JT, Vista ES, Dedeke AB, Thompson DM, Stewart S, Guthridge JM, Niewold TB,
Franek BS, Air GM, Thompson LF, James JA. Influenza vaccination responses in human systemic
lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011;63(8):2396-
406. Epub 2011/05/21. PMC3149742.
130. Nguyen AT, Feasley CL, Jackson KW, Nitz TJ, Salzwedel K, Air GM, Sakalian M. The prototype HIV-1
maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.
Retrovirology. 2011;8(1):101. Epub 2011/12/14.
131. Song X, Yu H, Chen X, Lasanajak Y, Tappert MM, Air GM, Tiwari VK, Cao H, Chokhawala HA, Zheng
H, Cummings RD, Smith DF. A sialylated glycan microarray reveals novel interactions of modified
sialic acids with proteins and viruses. J Biol Chem. 2011;286(36):31610-22. Epub 2011/07/16.
PMC3173124.
132. Tappert MM, Smith DF, Air GM. Fixation of oligosaccharides to a surface may increase the
susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase. J Virol.
2011;85(23):12146-59. Epub 2011/09/16. PMC3209406.
133. Yu Y, Mishra S, Song X, Lasanajak Y, Bradley KC, Tappert MM, et al. Functional glycomic analysis of
human milk glycans reveals the presence of virus receptors and embryonic stem cell biomarkers. J
Biol Chem. 2012; 287(53):44784-99. PMC3531791.
134. Venkatramani L, Johnson ES, Kolavi G, Air GM, Brouillette WJ, Mooers BH. Crystal structure of a new
benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite
C6. BMC Struct Biol. 2012; 12:7. Epub 2012/05/09. PMC3416664.
135. Popova L, Smith K, West AH, Wilson PC, James JA, Thompson LF, et al. Immunodominance of
Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses. PLoS One. 2012;
7(7):e41895. Epub 2012/08/01. PMC3405050.
136. Noronha JM, Liu M, Squires RB, Pickett BE, Hale BG, Air GM, et al. Influenza virus sequence feature
variant type analysis: evidence of a role for NS1 in influenza virus host range restriction. J Virol.
2012;86(10):5857-66. Epub 2012/03/09. PMC3347290.
137. Li Y, Silamkoti A, Kolavi G, Mou L, Gulati S, Air GM, et al. Pyrrolidinobenzoic acid inhibitors of
influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.
Bioorg Med Chem. 2012;20(14):4582-9. PMC3401542.
138. Gulati S, Lasanajak Y, Smith DF, Cummings RD, Air GM. Glycan array analysis of influenza H1N1
binding and release. Dis Markers. 2013; in press.
139. Couch RB, Decker WK, Utama B, Atmar RL, Niño D, Feng JQ, et al. Evaluations for in vitro correlates
of immunogenicity of inactivated influenza a h5, h7 and h9 vaccines in humans. PloS One. 2012;
7(12):e50830. PMC3519816.
140. Heimburg-Molinaro J, Tappert M, Song X, Lasanajak Y, Air G, Smith DF, Cummings RD. Probing
virus-glycan interactions using glycan microarrays. Methods Mol Biol. 2012;808:251-67. Epub
2011/11/08.
141. Vista ES, Crowe SR, Thompson LF, Air GM, Robertson JM, Guthridge JM, James JA. Influenza
vaccination can induce new-onset anticardiolipins but not beta2-glycoprotein-I antibodies among
patients with systemic lupus erythematosus. Lupus. 2012;21(2):168-74. PMC3268677.
Book chapters, Reviews etc
142. Air GM. DNA sequencing of viral genomes. In: Fraenkel-Conrat H, Wagner R, editors. Comprehensive
Virology: Plenum; 1979. p. 205-92.
143. Air GM. Sequences from the 3' ends of influenza virus RNA segments. In: Laver WG, Air G, editors.
Structure and Variation in Influenza Virus. North Holland: Elsevier; 1980. p. 135-46.
144. Blok J, Air GM. Sequence variations observed in the neuraminidases of several strains of influenza
virus. In: Laver WG, Air G, editors. Structure and Variation in Influenza Virus. North Holland: Elsevier;
1980. p. 125-34.
20

Gillian M. Air
145. Laver G, Air G. Structure and Variation in Influenza Virus. North Holland: Elsevier; 1980.
146. Laver WG, Air GM, Webster RG, Gerhard W, Ward CW, Dopheide TAA. The antigenic sites on
influenza virus hemagglutinin. Studies on their structure and variation. In: Laver G, Air G, editors.
Structure and Variation in Influenza Virus. North Holland: Elsevier; 1980. p. 295-308.
147. Air GM, Blok J, Hall RM. Sequence relationships in influenza viruses. In: Bishop DHL, Compans RW,
editors. The Replication of Negative Strand Viruses. New York: Elsevier; 1981. p. 225-39.
148. Air GM, Hall RM. Conservation and variation in influenza gene sequences. In: Nayak D, Fox CF,
editors. ICN-UCLA Symposia on Molecular and Cellular Biology XXII. New York: Academic Press;
1981. p. 29-44.
149. Laver WG, Air GM, Webster RG. Towards a universal influenza vaccine. In: Bishop DHL, Compans
RW, editors. The Replication of Negative Strand Viruses. New York: Elsevier; 1981. p. 421-5.
150. Laver WG, Air GM, Webster RG. Structure and variation of antigenic sites on influenza virus
hemagglutinin. In: Nayak D, Fox CF, editors. ICN-UCLA Symposia on Molecular and Cellular Biology
XXII. New York: Academic Press; 1981. p. 283-95.
151. Webster RG, Hinshaw VS, Berton MT, Laver WG, Air GM. Antigenic drift in influenza viruses and
association of biological activity with the topography of the hemagglutinin molecule. In: Nayak D, Fox
CF, editors. ICN-UCLA Symposia on Molecular and Cellular Biology XXII. New York: Academic Press;
1981. p. 309-22.
152. Gibbs A, Air GM, Laver G. Analysis of variation among hemagglutinin genes of influenza A viruses. In:
McKenzie J, editor. Viral Diseases in S E Asia and the Western Pacific. Sydney: Academic Press;
1982. p. 323-7.
153. Air GM, Blok J, Laver WG, Webster RG. Sequence changes associated with antigenic changes in the
influenza A virus neuraminidase. In: Laver WG, editor. The Origin of Pandemic Influenza Viruses. New
York: Elsevier; 1983. p. 97-102.
154. Air GM, Compans RW. Influenza B and influenza C viruses. In: Palese P, Kingsbury DW, editors.
Genetics of Influenza Viruses. Wien: Springer-Verlag; 1983. p. 280-304.
155. Laver WG, Webster RG, Air GM. Effect of chemical modification on the antigenic properties of
A/Tokyo/67 neuraminidase. Effect of a single sequence change on the thermal stability of A/Tokyo/67
neuraminidase. In: Laver WG, editor. The Origin of Pandemic Influenza Viruses: Elsevier; 1983. p.
113-20.
156. Webster RG, Laver WG, Air GM. Antigenic variation among type A influenza viruses. In: Palese P,
Kingsbury DW, editors. Genetics of Influenza Viruses. Wien: Springer-Verlag; 1983. p. 127-68.
157. Laver WG, Colman PM, Ward CW, Varghese JM, Air GM, Webster RG, Hinshaw V, Brown L, Jackson
D. Influenza virus neuraminidase: structure and variation. In: Stuart-Harris C, Potter CW, editors. The
Molecular Virology and Epidemiology of Influenza. London: Academic Press; 1984. p. 77-99.
158. Laver WG, Colman PM, Ward CW, Varghese JN, Air GM, Webster RG. Influenza virus neuraminidase:
Structure and variation. Molecular Biology of Negative Strand Viruses: Academic Press; 1984. p. 225-
32.
159. Air GM, Laver WG. Antigenic structure of influenza virus. In: Regenmortel MHV, Neurath AR, editors.
Immunochemistry of Viruses The basis for serodiagnosis and vaccines. Amsterdam: Elsevier; 1985. p.
213-39.
160. Laver WG, Air GM. Immune Recognition of Protein Antigens. New York: Cold Spring Harbor
Laboratory; 1985.
161. Air GM, Laver WG, Webster RG. Antigenic variation in influenza viruses. Contrib Microbiol Immunol.
1987/01/01 ed. Basel: Karger; 1987. p. 20-59.
162. Air GM, Lentz MR, Ritchie LR, Wei X, Hamilton AM. Expression and mutation of influenza antigen
genes using SV40 vectors. In: Mahy BWJ, Kolakofsky D, editors. The Biology of Negative Strand
Viruses: Elsevier; 1987. p. 55-62.
163. Laver WG, Webster RG, Bossart PJ, Luo M, Air GM. Recognition of protein antigens by antibodies:
crystal structure of antibody Fab fragments complexed with influenza virus neuraminidase. In: Smith-
Gill S, Sercarz E, editors. The Immune Response to Structurally Defined Proteins: The Lysozyme
Model: Adenine Press; 1989. p. 141-9.
164. Air GM, Laver WG. Antigenic structure of influenza viruses. In: Van Regenmortel MHV, Neurath AR,
editors. Immunochemistry of Viruses II. The Netherlands: Elsevier; 1990. p. 171-216.
21

Gillian M. Air
165. Laver WG, Air GM, editors. Use of X-ray Crystallography in the Design of Antiviral Agents. San Diego:
Academic Press; 1990.
166. Laver WG, Air GM, Luo M, Portner A, Thompson SD, Webster RG. Crystal structures of influenza virus
neuraminidase complexed with monoclonal antibody Fab fragments. In: Laver WG, Air GM, editors.
Use of X-ray Crystallography in Design of Antiviral Agents. San Diego: Academic Press; 1990. p. 49-
60.
167. Luo M, Air GM, Brouillette WJ. Design of aromatic inhibitors of influenza virus neuraminidase. In:
Brown LE, Hampson AW, Webster RG, editors. Options for the Control of Influenza III. Amsterdam:
Elsevier; 1996. p. 702-12.
168. Air GM, Luo M. Structure-guided therapeutic strategies: General overview. In: Chiu W, Burnett R,
Garcea R, editors. Structural Biology of Viruses: Oxford University Press; 1997. p. 411-31.
169. Zhang H, Air GM. Role of 5'-Untranslated region of influenza virus mRNAs in translational regulation
(Symposium in honour of Professor Wang Ying-Lai). Shanghai Institute of BIochemistry; 1997.
170. Stray SJ, Air GM. The Glycobiology of Influenza Viruses. In: Ernst B, Sinaÿ P, Hart GW, editors.
Oligosaccharides in Chemistry and Biology - a comprehensive handbook. Weinheim: Wiley-VCH;
2000. p. 839-50.
171. Stray SJ, Air GM. Evaluation of Influenza A virus receptors. In: Osterhaus AD, Hampson AW, Cox N,
editors. Options for the Control of Influenza IV. Amsterdam: Elsevier; 2001. p. 487-502.
172. Air GM. Influenzavirus B. In: Tidona CA, Darai G, editors. The Springer Index of Viruses. Heidelberg:
Springer-Verlag; 2002.
173. Air GM, West JT. Antigenic Variation. In: Mahy BW, van Regenmortel M, editors. Encyclopedia of
Virology. Third ed: Elsevier; 2008. p. 127-36.
174. Air GM, Brouillette WJ. Influenza virus antiviral targets. In: LaFemina R, editor. Antiviral Res.
Washington, DC: ASM Press; 2009. p. 187-207.
175. Tappert M, Air GM. Downstream consequences of glycan bindng by viruses 2010. Available from:
http://glycomics.scripps.edu/SubgroupWorkshop/WorkshopNov2010Rpt.pdf.
176. Air G. The Role of Carbohydrates in Viral Infections. In: Wang B, Boons G-J, editors. Carbohydrate
Recognition: Biological Problems, Methods, and Applications. Hoboken, New Jersey: John Wiley &
Sons; 2011. p. 65-92.
177. Air GM. Influenzavirus B. In: Tidona C, Darai G, editors. The Springer Index of Viruses. 2nd ed:
Springer; 2011. p. 1013-7.
178. Air GM. Influenza neuraminidase. Influenza Other Respi Viruses. 2012;6(4):245-56. Epub 2011/11/17.
22